Trachospray Device for Airway anesthesia

Trachospray Device for Airway anesthesia - Trachospray Device Evaluation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON48279

Enrollment

Registered

2019-11-21

Start date

2019-12-06

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway anesthesia Locoregional anesthesia of the airway

Interventions

Subjects will be asked to inhale (via the Trachospray device) 4 ml lidocaine 4%

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy ASA 1 patients between the age of 18 - 60 years old, with normal anatomy of the airways

Exclusion criteria

Exclusion criteria: Pregnancy, abnormal anatomy of the airways, allergy to amide type of local anesthetics

Design outcomes

Primary

Measure	Time frame
Complete anesthesia of the airway as evaluated and demonstrated by awake laryngobronchoscopy with minimal discomfort for the subject.	—

Secondary

Measure	Time frame
None	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)